Clinical Trial Update: Emicizumab in Patients With Acquired Hemophilia A [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating emicizumab for acquired hemophilia A is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Hemophilia

Drugs mentioned

• Emicizumab (emicizumab)

Snippet

Sponsor: University of Washington | Conditions: Acquired Hemophilia A | Phase 2 | Status: ACTIVE_NOT_RECRUITING